6.27
-0.91 (-12.67%)
| Penutupan Terdahulu | 7.18 |
| Buka | 6.64 |
| Jumlah Dagangan | 1,145,941 |
| Purata Dagangan (3B) | 1,154,562 |
| Modal Pasaran | 321,483,808 |
| Harga / Pendapatan (P/E Ke hadapan) | 22.99 |
| Harga / Jualan (P/S) | 0.490 |
| Harga / Buku (P/B) | 1.00 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 2 Nov 2026 |
| Margin Keuntungan | -13.63% |
| Margin Operasi (TTM) | 22.68% |
| EPS Cair (TTM) | -2.58 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -26.00% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 655.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 121.71% |
| Nisbah Semasa (MRQ) | 6.32 |
| Aliran Tunai Operasi (OCF TTM) | 110.10 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 91.12 M |
| Pulangan Atas Aset (ROA TTM) | -1.61% |
| Pulangan Atas Ekuiti (ROE TTM) | -21.63% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Bercampur | |
| Stok | Emergent BioSolutions Inc. | Bercampur | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | -1.5 |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 2.0 |
| Penilaian Relatif | 5.0 |
| Kesihatan Kewangan | NA |
| AI Insight | NA |
| Purata | 0.78 |
|
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 2.83% |
| % Dimiliki oleh Institusi | 67.20% |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| DEGOLYER DONALD W | - | 7.07 | -17,800 | -125,846 |
| Jumlah Keseluruhan Kuantiti Bersih | -17,800 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -125,846 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 7.07 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| DEGOLYER DONALD W | Pengarah | 07 Oct 2026 | Jual automatik (-) | 17,800 | 7.07 | 125,846 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |